Cureus

Lucy Kerr, MD

General Practice

CEO, Instituto Kerr · São Paulo, BRA

Create your FREE profile now!

Join the discussion with physicians and researchers around the globe - sign up for your free Cureus account today.

Similar Profiles

Sunil Kumar MD, PhD, Professor
Internal Medicine
210 Publications

Safeera Khan MD, MBBS
Family Medicine
207 Publications

R. Shane Tubbs PhD, Professor
Neurological Surgery
204 Publications

Giustino Varrassi Professor
Pain Management
203 Publications

Similar Profiles

Safeera Khan MD, MBBS
Family Medicine
207 Publications

Ayesha Akram Resident Physician
Internal Medicine
8 Publications

R. Shane Tubbs PhD, Professor
Neurological Surgery
204 Publications

John R. Adler Jr. MD, Professor
Neurological Surgery
35 Publications

Bruno Bordoni DO, PhD, Professor
Physical Medicine and Rehabilitation
56 Publications

Stats
Achievements (7)

Reviewer Rating

Published

Reviews

Rated

Complete Profile

10+ Article Downloads

Ivermectin Prophylaxis Used for COVID-19: A Cit...

20+ Article Downloads

Ivermectin Prophylaxis Used for COVID-19: A Cit...

Published First Article

Ivermectin Prophylaxis Used for COVID-19: A Cit...

100+ Article Downloads

Ivermectin Prophylaxis Used for COVID-19: A Cit...

Milestone - 5 Article Citations

Ivermectin Prophylaxis Used for COVID-19: A Cit...

50+ Article Downloads

Ivermectin Prophylaxis Used for COVID-19: A Cit...

Publications (2)

Recent article categories: Epidemiology/Public Health, Internal Medicine, Infectious Disease

Show:

All Articles (2)

Newest

7.7

August 31, 2022
Original Article

Regular Use of Ivermectin as Prophylaxis for COVID-19 Led Up to a 92% Reduction in COVID-19 Mortality Rate in a Dose-Response Manner: Results of a Prospective Observational Study of a Strictly Controlled Population of 88,012 Subjects

Lucy Kerr, Fernando Baldi, Raysildo Lobo, Washington Luiz Assagra, Fernando Carlos Proença, Juan J. Chamie, Jennifer A. Hibberd, Pierre Kory, Flavio A. Cadegiani

7.2

January 15, 2022
Original Article

Ivermectin Prophylaxis Used for COVID-19: A Citywide, Prospective, Observational Study of 223,128 Subjects Using Propensity Score Matching

Lucy Kerr, Flavio A. Cadegiani, Fernando Baldi, Raysildo B. Lobo, Washington Luiz O. Assagra, Fernando Carlos Proença, Pierre Kory, Jennifer A. Hibberd, Juan J. Chamie-Quintero

Infectious Disease

Show all